Skip to main content

MW 705.64 g/mol, Purity >99%. Cytochrome p450 CYP3A4 inhibitor (IC50 = 16-26 nM for midazolam hydroxylation). Higher affinity for fungal enzymes over mammalian cytochrome p450. Limited ability to cross the blood-brain barrier. Antifungal activity.

Be the first to review this product! Submit a review

Images

Chemical Structure - Itraconazole, Cytochrome p450 inhibitor (AB120816), expandable thumbnail
  • Functional Studies - Itraconazole, Cytochrome p450 inhibitor (AB120816), expandable thumbnail

Publications

Key facts

CAS number

84625-61-6

Purity

> 99%

Form

Solid

Molecular weight

705.64 g/mol

Molecular formula

C35H38Cl2N8O4

Nature

Synthetic

Recommended products

MW 705.64 g/mol, Purity >99%. Cytochrome p450 CYP3A4 inhibitor (IC50 = 16-26 nM for midazolam hydroxylation). Higher affinity for fungal enzymes over mammalian cytochrome p450. Limited ability to cross the blood-brain barrier. Antifungal activity.

Key facts

Purity

> 99%

Solubility

Soluble in DMSO to 50 mM. Soluble in ethanol to 10 mM (with warming).

Biological description

Cytochrome p450 CYP3A4 inhibitor (IC50 = 16-26 nM for midazolam hydroxylation). Higher affinity for fungal enzymes over mammalian cytochrome p450. Limited ability to cross the blood-brain barrier. Antifungal activity.

IUPAC name

4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one

Storage

Shipped at conditions

Ambient - Can Ship with Ice

Appropriate long-term storage conditions

-20°C

Storage information

It is important to note that this product is reported to be light sensitive, Store in the dark, Store under desiccating conditions

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - Itraconazole, Cytochrome p450 inhibitor (ab120816), expandable thumbnail

    Chemical Structure - Itraconazole, Cytochrome p450 inhibitor (ab120816)

    2D chemical structure image of ab120816, Itraconazole, Cytochrome p450 inhibitor

  • Functional Studies - Itraconazole, Cytochrome p450 inhibitor (ab120816), expandable thumbnail

    Functional Studies - Itraconazole, Cytochrome p450 inhibitor (ab120816)

    HepG2 cells were incubated at 37°C for 24h with vehicle control (0 μM) and different concentrations of itraconazole (ab120816). Increased expression of cytochrome P450 1A1 (ab3568) in HepG2 cells correlates with an increase in nifuroxazide concentration, as described in literature.

    Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated with ab3568 at 1/500 dilution and Anti-beta Actin antibody ab8227 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/10000 dilution and visualised using ECL development solution.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com